Link_TSG6: link protein for inflammatory bone disorders

Home / Link_TSG6: link protein for inflammatory bone disorders
Link_TSG6: link protein for inflammatory bone disorders
    • Product Overview: Novel link protein for treatment of bone inflammatory disorders
    • Primary Indication(s); Osteoporosis, Osteoarthritis
    • Core differentiators:
      1. Novel MoA
      2. Potent inhibition of bone resorption; minimal inhibition of none formation
      3. Associated with chondroprotective properties
      4. Inhibition of neutrophil migration
      5. Readily expressed in E coli – ‘drugable’
    • Development Stage: PreClinical
    • Company/ Institution: University of Manchester; manchester.ac.uk (www.manchester.ac.uk/research/Anthony.day/research)
    • Opportunity: Available for licensing, sponsored research and investment